Healthcare -
Biotechnology - NASDAQ - US
$ 1.865
-2.86 %
$ 154 M
Market Cap
-0.73
P/E
EDIT - COST OF REVENUE
Cost of Revenue EDIT - Editas Medicine, Inc.
178 M
LAST VALUE
492.94%
2 YEAR CAGR
14.40%
5 YEAR CAGR
60.26%
10 YEAR CAGR